Complete Consumer Guide · Updated May 2026
Semaglutide & Tirzepatide: Everything You Need to Know
May 2026 | BetterNewLives.com
Ozempic, Wegovy, Mounjaro, and Zepbound are among the most significant medications of the last decade — and among the most expensive, most confusing, and most unevenly accessible. This hub brings together every guide, tool, and resource we've built to help consumers navigate cost, coverage, quality, and access. All in one place.
⚡ Start Here — Most Useful First Steps
Interactive Tools
Tool
Find My Best GLP-1 Option
Answer 4 questions and get a personalized cost estimate, your best path forward, and direct next steps — based on your insurance, income, and medication.
Use tool →
Tool
Free Medication Eligibility Screener
Do you qualify for free Ozempic, Wegovy, Mounjaro, or Zepbound through a manufacturer patient assistance program? 4 questions, instant result.
Check eligibility →
Tool
Annual Cost Calculator
See the true 1-year and 5-year cost of your GLP-1 therapy. Compares telehealth, brand with savings card, insurance coverage, and compounded options side by side.
Calculate my cost →
Printable Checklist
Before Your Doctor Appointment
Print this before your visit. What to measure, document, and ask to maximize prior authorization approval — most PA denials happen because documentation was incomplete.
Get checklist →
Free Letter Templates — Prior Auth, Insurance Appeal, HR Request & More
5 copy-paste templates for the hardest GLP-1 coverage moments. Prior authorization support letter, insurance denial appeals (4 denial-reason variants), employer HR coverage request, hardship pricing email, and external review request. Free to copy and use.
Cost, Access & Savings
Guide
Why GLP-1 Programs Cost So Much
The medication costs ~$50 to produce. Programs charge $149–$499/month. This guide breaks down exactly where the margin goes — and how to pay less.
Read guide →
Guide
Savings Cards, PAPs & Free Medication
Lilly Cares, Novo Nordisk PAP, savings cards, GoodRx, state programs — every cost-reduction option, with eligibility requirements and how to apply.
Read guide →
Guide
GLP-1 Without Insurance
Self-pay options from $0 (patient assistance) to $99/mo (telehealth entry tier) to $900+ (brand-name retail). Your full menu of options when you're paying out of pocket.
Read guide →
Guide
How to Negotiate a Lower Program Price
Hardship pricing, pause vs. cancel strategy, competitor leverage scripts, and prepay discounts. Most programs have unpublished lower rates — here's how to access them.
Read guide →
Guide
Using HSA & FSA for GLP-1 Medications
Pay for semaglutide or tirzepatide with pre-tax dollars — a 20–37% effective discount. IRS eligibility rules, which indications qualify, LMN template, and telehealth program tips.
Read guide →
Guide
The True Cost of Not Treating Obesity
Diabetes: $9,600/yr. Knee replacement: $35,000. Cardiac event: $50,000–$150,000. How does a GLP-1 program compare to the downstream cost of inaction?
Read guide →
Insurance & Coverage Navigation
Guide
How to Get Insurance to Cover GLP-1 Medications
Prior auth, appeal letters, diagnosis codes, the diabetes vs. weight-loss label distinction that changes everything — and a step-by-step process that works.
Read guide →
Guide
Medicare & GLP-1 Medications
Medicare won't cover weight-loss GLP-1s. Savings cards are prohibited. What Medicare patients can actually do — including patient assistance programs and self-pay options.
Read guide →
Guide
Medicaid Coverage by State (2026)
Some states cover Wegovy and Zepbound through Medicaid. Others cover only diabetes indications. See the full state-by-state coverage breakdown.
Read guide →
Advocacy
How to Get Your Employer to Add Coverage
Self-funded employers control their own formulary. The ROI case, HR engagement strategy, and group request letter template to get GLP-1 coverage added to your plan.
Read guide →
Quality, Safety & Program Comparison
Clinical
Compounded vs. Brand-Name GLP-1
503A vs. 503B compounding pharmacies, FDA shortage framework, red flags and quality signals. What to look for before choosing a compounded program.
Read guide →
Guide
Program Hidden Terms: Fine Print Guide
Cancellation windows, refund policies, auto-renewal terms, dose-matching when you switch, and record portability — the terms programs don't advertise prominently.
Read guide →
Prices
Semaglutide Programs: Side-by-Side
Found, Hims & Hers, Noom Med, Henry Meds, Ro Body — entry prices, standard prices, what's included, and who each program is best for.
Compare programs →
Prices
Tirzepatide Programs: Side-by-Side
Henry Meds, Hims & Hers, Ro Body, Found, Eden — entry prices, standard prices, what's included, and program notes for tirzepatide.
Compare programs →
Clinical Understanding
Clinical
How Long Do You Need to Take GLP-1 Medications?
For most patients, benefits require long-term treatment. What the trial evidence shows, what this means for your financial planning, and the most sustainable long-term options.
Read guide →
Clinical
What Happens When You Stop
The STEP-4 trial: most people regain 2/3 of lost weight within one year of stopping. What that means, maintenance dose options, and what to do if cost forces a stop.
Read guide →
Clinical
Managing Side Effects — Stay on Treatment
Nausea, fatigue, and GI changes are the #1 reason people quit. Evidence-based strategies to manage each side effect, slow escalation timing, and red flags to watch for.
Read guide →
Clinical
Semaglutide vs. Tirzepatide: Which Is Right for You?
Head-to-head comparison of the two leading GLP-1 medications. STEP-1 vs. SURMOUNT-1 trial data, side effect differences, cost, coverage, and which to ask about for your situation.
Read guide →
Live Price Comparisons
Live Data
Semaglutide Prices
Current prices from research suppliers, telehealth programs, and brand-name (Ozempic, Wegovy) — updated regularly from sourced submissions.
See prices →
Live Data
Tirzepatide Prices
Current prices for tirzepatide across research, telehealth, and brand-name (Mounjaro, Zepbound) sources — updated regularly.
See prices →
Live Data
Retatrutide Prices
The next-generation GLP-1/GIP/glucagon triple agonist. Current research and emerging telehealth pricing as this molecule approaches clinical use.
See prices →
Complete Guide Index
Every page in this resource, organized alphabetically.
→ Appeal & Prior Auth Letter Templates
→ Before Your Appointment Checklist
→ Compounded GLP-1: Quality & Safety Guide
→ Annual Cost Calculator
→ Cost of Not Treating Obesity
→ Cost Finder: Find My Best Option (Tool)
→ Duration Guide: How Long to Take GLP-1s
→ Employer Benefits Advocacy Toolkit
→ Insurance Coverage Guide
→ Medicaid Coverage by State
→ Medicare & GLP-1 Guide
→ Negotiate a Lower Program Price
→ PAP Eligibility Screener (Free Medication)
→ Program Cost Breakdown Guide
→ Program Hidden Terms & Fine Print
→ Savings Cards, PAPs & Assistance Guide
→ HSA & FSA Eligibility Guide
→ Semaglutide vs. Tirzepatide Comparison
→ Side Effects Management Guide
→ Stopping & Discontinuation Guide
→ Without Insurance: Self-Pay Options
→ Semaglutide Price Comparison (Live)
→ Semaglutide Programs Comparison
→ Tirzepatide Price Comparison (Live)
→ Tirzepatide Programs Comparison
→ Retatrutide Prices (Next-Gen GLP-1)